Browse by Poster Presenter

Skip to main content

ASCPT 2023 Annual Meeting Main banner

Tweets by ASCPT 2023 Annual Meeting

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

A
Abutarif, Malaz

Daiichi Sankyo
PI-016 - EFFECT OF MILD AND MODERATE HEPATIC IMPAIRMENT ON QUIZARTINIB PHARMACOKINETICS.
Malaz Abutarif
Favorite
Ahmed, Nusrat

University of Nebraska Medical Center
PII-121 - CONTRIBUTION OF INFLAMMATION AND OBESITY TO VARIABILITY IN MIDAZOLAM PHARMACOKINETICS IN CHILDREN.
Nusrat Ahmed
Favorite
Ajavon-Hartmann, Toni

Bristol Myers Squibb
PII-063 - MODELING AND SIMULATION TO SUPPORT APIXABAN DOSE RECOMMENDATION FOR THROMBOEMBOLISM PREVENTION IN PEDIATRIC SUBJECTS WITH CONGENITAL OR ACQUIRED HEART DISEASE REQUIRING ANTICOAGULATION – SAXOPHONE STUDY.
Toni Ajavon-Hartmann
Favorite
Aldhafiri, Wafaa

University of Nebraska Medical Center
PT-024 - PHARMACOKINETICS AND TISSUE DISTRIBUTION OF A LIPID-BASED EXTENDED-RELEASE NANO-FORMULATION OF MO-OH-NAP TROPOLONE TO ENHANCE PULMONARY DELIVERY.
Wafaa Aldhafiri
Favorite
Alghamdi, Alaa

Cincinnati Children's Hospital Medical Center
PT-009 - ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT.
Alaa Alghamdi
Favorite
Alkhafaji, Silver

University of California, San Francisco
PII-081 - POPULATION PHARMACOKINETICS (PK) OF ETHAMBUTOL IN TUBERCULOSIS PATIENTS – TUBERCULOSIS TRIALS CONSORTIUM (TBTC) STUDY A5349/S31.
Silver Alkhafaji
Favorite
Almoslem, Mohammed

University of Florida
PII-072 - PHARMACOKINETICS AND PHARMACODYNAMICS MODELING OF ACETAMINOPHEN AND IBUPROFEN TO EVALUATE THE TIME TO PATENT DUCTUS ARTERIOSUS CLOSURE IN PRETERM NEONATES.
Mohammed Almoslem
Favorite
Alrajeh, Khalifa

Virginia Commonwealth University
PI-032 - THE FREQUENCY OF SLCO1B1*5 IN WOMEN OF ASIAN, NATIVE HAWAIIAN, AND PACIFIC ISLANDERS SUBGROUPS: STEPS TO INCREASE RACIAL DIVERSITY IN PHARMACOGENETIC RESEARCH.
Khalifa Alrajeh
Favorite
PWIV-005 - THE FREQUENCY OF SLCO1B1*5 IN WOMEN OF ASIAN, NATIVE HAWAIIAN, AND PACIFIC ISLANDERS SUBGROUPS: STEPS TO INCREASE RACIAL DIVERSITY IN PHARMACOGENETIC RESEARCH.
Khalifa Alrajeh
Favorite
Amore, Benny

Esperion Therapeutics, Inc.
PI-057 - DOSE–RESPONSE MODEL PREDICTIONS OF THE PHARMACODYNAMIC EFFECT OF BEMPEDOIC ACID, A COMPETITIVE INHIBITOR OF ATP CITRATE LYASE, IN COMBINATION WITH EZETIMIBE AND STATINS.
Benny Amore
Favorite
Anderson, Kacey

EQRx International, Inc.
PII-113 - PHARMACOKINETICS OF AUMOLERTINIB IN HEALTHY CHINESE SUBJECTS AND NON-CHINESE SUBJECTS.
Kacey Anderson
Favorite
Arslan, Meliksah

Marmara University School of Medicine
PII-032 - SUBSTANCE USE DISORDERS: GLUCOCORTICOID SIGNALING REGULATES THE EXPRESSION OF PTPRD IN HUMAN CNS CELLS.
Meliksah Arslan
Favorite
Asao, Tetsuhiko

Juntendo University Hospital
PII-038 - MULTICENTER PHARMACOKINETIC STUDY OF PEMBROLIZUMAB FOR NON-SMALL CELL LUNG CANCER IN OLDER ADULTS AGED OVER 75 YEARS.
Tetsuhiko Asao
Favorite
Asthana-Nijjar, Rashi

University of Toronto
PT-003 - EXPRESSION OF ABCB1 IS DECREASED IN PLACENTA OF WOMEN WITH AUTOIMMUNE DISEASE AND IN CYTOKINE- TREATED PLACENTAL EXPLANTS.
Rashi Asthana-Nijjar
Favorite
Avachat, Charul

University of Minnesota
PI-083 - CHARACTERIZATION OF THE US FOOD AND DRUG ADMINISTRATION POST-MARKETING COMMITMENTS AND REQUIREMENTS FOR PREGNANCY AND LACTATION.
Charul Avachat
Favorite